CALLIDITAS THERAPEUTICS AB's ticker is CALT and the CUSIP is 13124Q106. A total of 18 filers reported holding CALLIDITAS THERAPEUTICS AB in Q3 2023. The put-call ratio across all filers is 10.22 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $240,265 | +29.1% | 13,158 | +11.0% | 0.00% | – |
| Q2 2023 | $186,092 | -76.8% | 11,853 | -64.6% | 0.00% | – |
| Q1 2023 | $802,325 | +26.2% | 33,500 | -7.6% | 0.00% | – |
| Q4 2022 | $635,690 | +53.2% | 36,263 | +31.9% | 0.00% | – |
| Q3 2022 | $415,000 | +117.3% | 27,500 | +167.0% | 0.00% | – |
| Q1 2022 | $191,000 | -84.2% | 10,300 | -78.9% | 0.00% | – |
| Q4 2021 | $1,211,000 | +358.7% | 48,900 | +410.9% | 0.00% | – |
| Q1 2021 | $264,000 | -82.2% | 9,571 | -84.9% | 0.00% | -100.0% |
| Q2 2020 | $1,480,000 | – | 63,551 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 200,000 | $6,724,000 | 2.33% |
| BVF INC/IL | 750,000 | $25,493,000 | 1.00% |
| Logos Global Management LP | 300,000 | $10,086,000 | 0.86% |
| Vivo Capital, LLC | 311,030 | $10,457,000 | 0.47% |
| HHLR ADVISORS, LTD. | 1,047,687 | $35,611,000 | 0.28% |
| Pentwater Capital Management LP | 50,000 | $1,681,000 | 0.02% |
| Point72 Asset Management, L.P. | 102,748 | $3,454,000 | 0.02% |
| DEUTSCHE BANK AG\ | 70,236 | $2,361,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 20,484 | $696,000 | 0.00% |
| JANE STREET GROUP, LLC | 7,557 | $256,000 | 0.00% |